Navigation Links
NYU Langone Medical Center awarded NIH grants totaling $1,560,000
Date:6/24/2009

New York, NY, June 24, 2009 Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH). The studies being conducted at NYU Langone Medical Center are two of several projects being conducted through the NIH Roadmap for Medical Research as part of the Human Microbiome Project (HMP) taking place at institutions across the country.

Since 2007, the HMP has awarded more than $70 million to expand its exploration of how the trillions of microscopic organisms that live in and on our bodies affect our health. The human microbiome is all the microorganisms that reside in or on the human body, as well as all their DNA, or genomes.

In the new round of funding, the HPM will support pilot demonstration projects by researchers that will sample the microbiomes of healthy volunteers and volunteers with specific diseases over the next year. As part of that funding, Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine, chair of the Department of Medicine, and professor of microbiology, will receive support for his study titled "Evaluation of the Cutaneous Microbiome in Psoriasis." Psoriasis, affecting more than 7.5 million people in the United States, is a chronic disease involving the immune system that appears on the skin, usually in the form of thick, red, scaly patches, and its cause is unknown. The goal of this study is to assess whether changes in the skin microbiome may contribute to psoriasis.

Additionally, Zhiheng Pei, MD, PhD, assistant professor of pathology and medicine, will receive a grant to support his study on microbiome and esophageal cancer. Dr. Pei's work focuses on the type of cancer linked to heartburn due to gastroesophageal reflux diseases, the fastest rising malignancy in the United States. The recent increases in this canc
'/>"/>

Contact: Lisa Greiner
lisa.greiner@nyumc.org
212-404-3532
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008
2. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
3. American College of Medical Genetics responds to new FDA labeling decision for warfarin
4. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
5. Boston University biomedical engineers find chink in bacterias armor
6. $22 million gift from Alfred Taubman launches new biomedical research institute
7. USC biomedical team to participate in $6 million low vision project
8. 3 Columbia University Medical Center faculty elected to Institute of Medicine
9. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
10. UMass Medical School researchers receive $8.5M grant award to fight AIDS
11. Natural product discovery by Cleveland medical researchers blocks tissue destruction

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Kent State University assistant professors recentl...ation (NSF) to continue research beneficial to und... $890,000. , Christopher Blackwood, assistant pr...was awarded grants to support two separate researc...ing Litter Decomposer Communities and Functions fr...
(Date:11/24/2009)...Lupus Research Institute (LRI) today named 12 new ....6 million, recognize innovative work across a bro...or their creativity, novelty, and potential to dri...at, and cure the complex disease of systemic lupus...ed lupus researchers across the nation and include...
(Date:11/24/2009)...ts that keep weakened and flabby arteries from col...months, those stents are no longer needed -- once ...sary. Previously, doctors had no choice but to lea...l Aviv University,s Department of Biomedical Engin...atform that carries drugs where they,re needed, th...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 1Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 1Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 3Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 4Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 1Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 2
...uman immunodeficiency virus (HIV-1) molecular mach...functionally-specialized layers, according to a st...ia San Diego (UCSD) Antiviral Research Center (AVR...ology. , The unprecedented genetic diversity an... efforts to eradicate the global HIV/AIDS epidemic...
...uld More Than Double its Current Revenue, Stream...care Industry, SAN JOSE, Calif., Nov. 2 Titanium...ing biometric and security,solutions provider, ann...tent to acquire China Medical Systems (OTC: CHSY),...ching, developing and marketing of specialized,sof...
...d streams in remote parts of the UK, southern Scan...singly stained brown by dissolved organic matter. ...rnational team, led by researchers from UCL (Unive...tection Agency (EPA), demonstrates that the colour...l, pre-industrial state following a decline in the...
Other Biology News:Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 2Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 3Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 4Don't judge a brook by its color -- brown waters are more natural 2
(Date:11/24/2009)...acy endpoint has been met for patients with advanc..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - A...he "Company"), a global biopharmaceutical company ...nnounced positive efficacy data from a Phase 2 stu...AEZS-108 (formerly AN-152), in patients with advan...
(Date:11/24/2009)... 24, 2009 Arena Pharmace...hat the company is scheduled to present at the Pip...ecember 1, 2009 at 11:30 a.m. Eastern Time (8:30 a...New York City. Jack Lief, Arena,s President and Ch...overview of the company, including its clinical de...
(Date:11/24/2009)...am Connects Customers with Partners Validated to P...tek Products , Ottawa, ON...ding provider of products for biological sample co...ounced its new global partner program. The program... partner community and is designed to help partner...
(Date:11/23/2009)...9 In a provocative new study, a University of Uta...sions the major cause of global warming cannot b...or society builds the equivalent of one new nuclea...at there will be any substantial near-term departu...ioxide emission rates," says the new paper by Tim ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...6 Zounds Hearing, a unique manufacturing,and reta...th state-of-the-art,fidelity, price point and prof...sistive listening devices (ALDs) in an effort to a...s are now available in all of the Zounds Hearing,C...8. And, from November 26,2008, through December 7...
... 26 Ceregene, Inc., a biopharmaceutical,company, ...controlled Phase 2,trial of CERE-120 in 58 patient...d not demonstrate an appreciable difference betwee...he control group. Both groups showed an approximat...ary endpoint (Unified,Parkinson,s Disease Rating S...
...Nov. 26 Covaris Incorporated today,announced that... the shipment,of its 500th instrument unit and con...o accommodate this rapid business growth, Covaris ...nization as well as implementing a,50% expansion o...was built upon the proprietary and patented AFA(TM...
Other Biology Technology:Zounds Offers the Gift of Hearing This Holiday Season With a Range of New Products 2Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease 2Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease 3Covaris Installed Instrument Base Reaches 500 Units 2
...Adept CE 4100 high pressure dual piston pumps, eac...nts. The ground breaking WaveQuest UV/Visible ult...ity. The WaveQuest provides a trustworthy altern... superior stability . Hence only one detector is ...
...ples may be carried out using this high pressure s...System control and data processing is provided by ...legant, powerful and very easy to use software ope... supplied detector is the ground breaking WaveQues...
Oligonucleotides from Thermo Scientific
Pyrex brand low actinic narrow mouth Erlenmeyer flask, Pyrex ST 27 stopper from Sigma-Aldrich
Biology Products: